Company news
Pacific Biosciences of California, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
PacBio Announces Appointment of Genomics Industry Veteran Jeff Eidel as Chief Commercial Officer
July 20, 2022
PacBio to Report Second Quarter 2022 Financial Results on August 3, 2022
July 17, 2022
PacBio to Participate in the BofA Securities 2022 Healthcare Conference
May 4, 2022
PacBio Announces First Quarter 2022 Financial Results
May 3, 2022
PacBio transforms access to the epigenome and streamlines workflows
April 20, 2022
PacBio and Children’s Mercy Kansas City Expand Collaboration Taking a Multi-Omics Approach to Characterize Rare Disease
April 20, 2022
PacBio to Report First Quarter 2022 Financial Results on May 4, 2022
April 19, 2022
PacBio Enters Agricultural Industry Collaboration with Corteva Agriscience to Develop High-Throughput Plant, Pest and Microbial Sequencing
April 3, 2022
HiFi Reads Enable Telomere-to-Telomere Consortium to Fill the Final Gaps in the Human Genome, Heralding a New Era of Research into Genetic Diseases and Human Biology
March 30, 2022
PacBio Opens European Headquarters in London
March 22, 2022
PacBio Supports SickKids to Investigate Use of HiFi Sequencing in Undiagnosed Genetic Conditions
February 27, 2022
PacBio Welcomes Dr. Michael Eberle as Vice President of Computational Biology
February 22, 2022
KK Women’s and Children’s Hospital and PacBio Collaborate in Asia’s First Study of Unexplained Neurodevelopmental Disorders
February 15, 2022
PacBio Announces Fourth Quarter and Fiscal Year 2021 Financial Results
February 14, 2022
PacBio to Report Fourth Quarter and Full Year 2021 Financial Results on February 15, 2022
January 31, 2022
PacBio Names Lara Toerien as Vice President and General Manager for the Americas
January 12, 2022
PacBio Announces Record Preliminary Fourth Quarter 2021 Revenue, New Sequencing Kits and Workflows, and Expanded Collaborations
January 10, 2022
PacBio Announces Collaboration with Genomics England to Sequence Biobanked Rare Disease Samples Using HiFi Sequencing Technology
January 10, 2022
PacBio and Google Collaborate to Use Machine Learning to Optimize Long-Read Sequencing Data Analysis
January 10, 2022
PacBio and Berry Genomics Announce Collaboration to Bring Long Read Desktop Sequencing Instrument to the Clinical Market in China
January 10, 2022
Radboud University Medical Center Increases HiFi Sequencing Capacity with PacBio’s Sequel IIe
January 6, 2022
PacBio and Care4Rare Consortium Collaborate on Rare Disease Research Study
January 4, 2022
PacBio to Present at Upcoming Investor Conference
January 3, 2022
PacBio’s New HiFiViral Surveillance Kit Performance is Not Impacted by Omicron Mutations, Delivering Complete SARS-CoV-2 Genomes for All Circulating Variants
December 27, 2021
PacBio and UCLA Health Announce Research Collaboration for Whole Genome Sequencing in Rare Diseases
December 6, 2021
PacBio Names Jason Kang as Vice President and General Manager for Asia-Pacific Region
November 29, 2021
PacBio and ARUP Laboratories Collaborate in a Study to Improve Rare Disease Diagnosis
November 17, 2021
PacBio Launches HiFiViral SARS-CoV-2 Kit and Microbial Whole Genome Sequencing Enhancements to Combat Infectious Disease and Strengthen Public Health Response to Pathogen Threats
November 15, 2021
PacBio’s Sequel IIe Selected by Prenetics to Build Personalized Genomics for Healthcare
November 1, 2021
PacBio Announces Third Quarter 2021 Financial Results
November 1, 2021
Pacific Biosciences of California, Inc. Third Quarter 2021 Financial Results Call
October 18, 2021
PacBio Partners with The European Reference Genome Atlas Initiative
September 26, 2021
Pacific Biosciences Grants Equity Incentive Award to New Employee
September 23, 2021
Pacific Biosciences Closes Acquisition of Omniome and Establishes San Diego Presence
September 19, 2021
Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conferences
September 2, 2021
Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conference
August 8, 2021
Pacific Biosciences of California, Inc. Announces Second Quarter 2021 Financial Results
August 2, 2021
Pacific Biosciences Acquires Circulomics – A Leading High Molecular Weight DNA Extraction Company
August 2, 2021
Pacific Biosciences Signs Definitive Agreement to Acquire Omniome
July 19, 2021
Pacific Biosciences and Invitae Announce Intent to Expand Collaboration
July 19, 2021
Pacific Biosciences of California, Inc. Second Quarter 2021 Financial Results Call
July 18, 2021
Pacific Biosciences and Rady Children’s Institute for Genomic Medicine Announce its First Research Collaboration for Whole Genome Sequencing
June 22, 2021
Pacific Biosciences Welcomes Neil Ward to Its Leadership Team as Vice President and General Manager for Europe, Middle East, and Africa
June 7, 2021
Pacific Biosciences Further Expands Leadership Team with Appointment of Dr. Catherine Ball to Newly Created Position of Senior Vice President of Research
May 16, 2021
Pacific Biosciences of California, Inc. Announces First Quarter 2021 Financial Results
April 28, 2021
Pacific Biosciences Nominates Dr. Hannah Valantine to its Board of Directors
April 26, 2021
Pacific Biosciences Launches New HiFi Sequencing Workflow to Further Improve HiFi’s Industry Leading Accuracy
April 25, 2021
Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19
February 17, 2021
Pacific Biosciences of California, Inc. Announces Fourth Quarter and Fiscal Year 2020 Financial Results
February 9, 2021
Pacific Biosciences Grants Equity Incentive Awards to New Employees
January 11, 2021
Calls
The 5 newest of 23 calls. Every call is listed under its year.
- Pacific Biosciences of California (NASDAQ:PACB) Q2 2026 Earnings Call
Aug 5, 2026
Transcript - Pacific Biosciences of California (NASDAQ:PACB) Q1 2026 Earnings Call
May 7, 2026
Transcript - Pacific Biosciences of California (NASDAQ:PACB) Q4 2025 Earnings Call
Feb 12, 2026
Transcript - Pacific Biosciences of California (NASDAQ:PACB) Q3 2025 Earnings Call
Nov 5, 2025
Transcript - Pacific Biosciences of California (NASDAQ:PACB) Q2 2025 Earnings Call
Aug 7, 2025
Transcript
Decks
The 5 newest of 6 decks. Every deck is listed under its year.
- Q2 2026 Earnings Presentation
Earnings · 17 slides · Aug 5, 2026
- Q1 2026 Earnings Presentation
Earnings · 16 slides · May 7, 2026
- Q4 2025 Earnings Presentation
Earnings · 22 slides · Feb 12, 2026
- Technical Presentation (February 2024)
Technical · 16 slides · Feb 21, 2024
- Shareholder Meeting (May 2022)
Shareholder meeting · 14 slides · May 9, 2022